R
77
2
RRC
60
-3
RCL
88
-2
KO
44
2
BAX
27
-2
T
48
3
QCOM
55
-2
TROW
51
-2
AIG
47
6
LEG
31
3
VLO
42
2
URBN
66
2
QRVO
4
-2
NWSA
71
-2
STX
52
-4
NKE
33
2
MU
32
-6
AVGO
35
-2
LB
63
-4
DD
61
4
R
77
2
RRC
60
-3
RCL
88
-2
KO
44
2
BAX
27
-2
T
48
3
QCOM
55
-2
TROW
51
-2
AIG
47
6
LEG
31
3
VLO
42
2
URBN
66
2
QRVO
4
-2
NWSA
71
-2
STX
52
-4
NKE
33
2
MU
32
-6
AVGO
35
-2
LB
63
-4
DD
61
4
Financhill
Back

Rocket Pharmaceuticals Vs. ePlus Industry Stock Comparison

Sell
33

RCKT
Rocket Pharmaceuticals

Last Price:
15.35
Seasonality Move:
12.47%
Sell
27

PLUS
ePlus

Last Price:
80.60
Seasonality Move:
20.86%
Sell
33
Rocket Pharmaceuticals (RCKT) is a Sell

Is Rocket Pharmaceuticals a Buy, Sell or Hold?

  • The current Rocket Pharmaceuticals [RCKT] share price is $15.67. The Score for RCKT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • RCKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
ePlus (PLUS) is a Sell

Is ePlus a Buy, Sell or Hold?

  • The current ePlus [PLUS] share price is $80.03. The Score for PLUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • PLUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RCKT Stock Price Chart

What is Rocket Pharmaceuticals's stock price today?

  • The Rocket Pharmaceuticals share price today is $15.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing selling pressure, which indicates risk of future bearish movement.

PLUS Stock Price Chart

What is ePlus's stock price today?

  • The ePlus share price today is $80.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLUS is experiencing selling pressure, which indicates risk of future bearish movement.

RCKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 36.28 Sell
Chaikin Money Flow: -696644 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.51 - 17.75) Sell
Bollinger Bands (100): (17.05 - 21.99) Sell

PLUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.37 Sell
Relative Strength Index (14 RSI): 28.12 Sell
Chaikin Money Flow: -371573 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.15 - 100.85) Sell
Bollinger Bands (100): (81.19 - 98.29) Sell

RCKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.85 Sell
20-day SMA: 17.22 Sell
50-day SMA: 17.9 Sell
200-day SMA: 22.4 Sell
8-day EMA: 16.64 Sell
20-day EMA: 17.04 Sell
50-day EMA: 17.87 Sell
200-day EMA: 20.68 Sell

PLUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 93.25 Sell
20-day SMA: 94.97 Sell
50-day SMA: 95.27 Sell
200-day SMA: 83.59 Sell
8-day EMA: 92.26 Sell
20-day EMA: 94.28 Sell
50-day EMA: 94.05 Sell
200-day EMA: 84.44 Sell

Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.27 per share.

ePlus Earnings Growth & PLUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.

Rocket Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ePlus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):